SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 24th, 2021 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • Delaware
This Securities Purchase Agreement (this “Agreement”), dated as of August 19, 2021, is made by and among Palisade Bio, Inc., a Delaware corporation (the “Company”), and the Purchaser listed on Exhibit A hereto, together with its permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”).
FORM OF WARRANTWarrant Agreement • August 24th, 2021 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS CERTIFIES THAT, for value received, Yuma Regional Medical Center or its permitted assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Palisade Bio, Inc., a Delaware corporation (the “Company”), up to 377,474 shares of the Common Stock of the Company (the “Common Stock”), subject to adjustment as provided herein. This Warrant is one of a series of Warrants being issued pursuant to the terms of the Securities Purchase Agreement, dated August 19, 2021, by and among the Company and the original Holder of this Warrant and the other parties named therein (the “Purchase Agreement”). Capitalized terms not otherwise defined herein shall have the respective meanings ascribed to such terms in the Purchase Agreement.
